Mani Past Earnings Performance
Past criteria checks 1/6
Mani has been growing earnings at an average annual rate of 11%, while the Medical Equipment industry saw earnings growing at 6.2% annually. Revenues have been growing at an average rate of 12.3% per year. Mani's return on equity is 12%, and it has net margins of 22%.
Key information
11.0%
Earnings growth rate
11.0%
EPS growth rate
Medical Equipment Industry Growth | 7.8% |
Revenue growth rate | 12.3% |
Return on equity | 12.0% |
Net Margin | 22.0% |
Next Earnings Update | 08 Jan 2025 |
Recent past performance updates
Recent updates
Mani (TSE:7730) Strong Profits May Be Masking Some Underlying Issues
Oct 15JP¥2,258: That's What Analysts Think Mani, Inc. (TSE:7730) Is Worth After Its Latest Results
Oct 09Mani's (TSE:7730) Shareholders Will Receive A Bigger Dividend Than Last Year
Aug 28Mani's (TSE:7730) Dividend Will Be Increased To ¥23.00
Aug 14Mani (TSE:7730) Has Announced That It Will Be Increasing Its Dividend To ¥23.00
Jul 30Mani (TSE:7730) Is Increasing Its Dividend To ¥23.00
Jul 16Mani's (TSE:7730) Dividend Will Be Increased To ¥23.00
May 31Mani's (TSE:7730) Dividend Will Be Increased To ¥23.00
Apr 25Mani's (TSE:7730) Dividend Will Be Increased To ¥23.00
Apr 10Is Now The Time To Put Mani (TSE:7730) On Your Watchlist?
Mar 14Mani's (TSE:7730) Dividend Will Be ¥16.00
Feb 27Revenue & Expenses Breakdown
How Mani makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Aug 24 | 28,513 | 6,286 | 9,505 | 0 |
31 May 24 | 27,577 | 6,830 | 6,861 | 2,187 |
29 Feb 24 | 26,371 | 6,581 | 6,419 | 2,187 |
30 Nov 23 | 25,497 | 6,227 | 5,973 | 2,187 |
31 Aug 23 | 24,488 | 5,953 | 5,650 | 2,187 |
31 May 23 | 24,107 | 5,705 | 5,939 | 1,560 |
28 Feb 23 | 22,790 | 5,520 | 5,377 | 1,560 |
30 Nov 22 | 21,793 | 5,267 | 5,058 | 1,560 |
31 Aug 22 | 20,416 | 5,290 | 4,533 | 1,560 |
31 May 22 | 19,085 | 4,601 | 4,286 | 1,498 |
28 Feb 22 | 18,537 | 4,610 | 4,069 | 1,498 |
30 Nov 21 | 17,719 | 4,629 | 3,928 | 1,498 |
31 Aug 21 | 17,190 | 4,291 | 3,885 | 1,498 |
31 May 21 | 16,272 | 3,960 | 3,622 | 1,589 |
28 Feb 21 | 15,029 | 3,037 | 3,518 | 1,589 |
30 Nov 20 | 15,054 | 3,263 | 3,546 | 1,589 |
31 Aug 20 | 15,200 | 3,329 | 3,696 | 1,589 |
31 May 20 | 16,412 | 3,845 | 3,673 | 1,693 |
29 Feb 20 | 17,714 | 4,373 | 3,896 | 1,693 |
30 Nov 19 | 17,871 | 4,065 | 3,789 | 1,693 |
31 Aug 19 | 18,327 | 6,101 | 3,854 | 1,693 |
31 May 19 | 18,914 | 6,156 | 4,282 | 1,614 |
28 Feb 19 | 19,527 | 6,126 | 4,593 | 1,614 |
30 Nov 18 | 20,195 | 6,013 | 4,945 | 1,614 |
31 Aug 18 | 20,102 | 3,770 | 4,995 | 1,614 |
31 May 18 | 19,741 | 3,577 | 5,238 | 1,221 |
28 Feb 18 | 18,625 | 3,298 | 4,837 | 1,221 |
30 Nov 17 | 17,839 | 3,316 | 4,522 | 1,221 |
31 Aug 17 | 17,167 | 3,315 | 4,260 | 1,221 |
31 May 17 | 16,815 | 3,163 | 4,054 | 1,278 |
28 Feb 17 | 16,942 | 3,467 | 3,919 | 1,278 |
30 Nov 16 | 16,586 | 3,284 | 3,967 | 1,278 |
31 Aug 16 | 16,555 | 3,005 | 3,986 | 1,278 |
31 May 16 | 16,488 | 3,044 | 4,158 | 1,212 |
29 Feb 16 | 15,520 | 2,830 | 3,760 | 1,212 |
30 Nov 15 | 14,944 | 2,800 | 3,243 | 1,212 |
31 Aug 15 | 13,833 | 2,932 | 2,766 | 1,212 |
31 May 15 | 12,489 | 2,831 | 2,403 | 1,061 |
28 Feb 15 | 12,097 | 2,655 | 2,382 | 1,061 |
30 Nov 14 | 11,641 | 2,714 | 2,289 | 1,061 |
31 Aug 14 | 11,440 | 2,606 | 2,162 | 1,061 |
31 May 14 | 11,131 | 2,635 | 2,196 | 801 |
28 Feb 14 | 10,486 | 2,499 | 1,993 | 801 |
30 Nov 13 | 9,967 | 2,341 | 1,853 | 801 |
Quality Earnings: 7730 has a high level of non-cash earnings.
Growing Profit Margin: 7730's current net profit margins (22%) are lower than last year (24.3%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 7730's earnings have grown by 11% per year over the past 5 years.
Accelerating Growth: 7730's earnings growth over the past year (5.6%) is below its 5-year average (11% per year).
Earnings vs Industry: 7730 earnings growth over the past year (5.6%) did not outperform the Medical Equipment industry 5.7%.
Return on Equity
High ROE: 7730's Return on Equity (12%) is considered low.